Literature DB >> 15428452

Deuterium studies in normal man. I. The rate of synthesis of serum cholesterol. II. Measurement of total body water and water absorption.

I M LONDON, D RITTENBERG.   

Abstract

Entities:  

Keywords:  CHOLESTEROL; DEUTERIUM; WATER

Mesh:

Substances:

Year:  1950        PMID: 15428452

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  7 in total

1.  Effect of cholesterol synthesis inhibition in normocholesteremic young men.

Authors:  G L CURRAN; D L AZARNOFF; R E BOLINGER
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

2.  Cholesterol synthesis from C14-acetate in man.

Authors:  L HELLMAN; R S ROSENFELD; T F GALLAGHER
Journal:  J Clin Invest       Date:  1954-02       Impact factor: 14.808

3.  Erythrocyte metabolism; the metabolic behavior of the cholesterol of human erythrocytes.

Authors:  I M LONDON; H SCHWARZ
Journal:  J Clin Invest       Date:  1953-12       Impact factor: 14.808

4.  [Deuterium and oxygen-18 contents in the body fluids of man and their deviations due to change of location].

Authors:  U Zimmermann; U Cegla
Journal:  Naturwissenschaften       Date:  1973-05

5.  Effect of neomycin on exchangeable pools of cholesterol in the steady state.

Authors:  P Samuel; C H Holtzman; E Meilman; W Perl
Journal:  J Clin Invest       Date:  1968-08       Impact factor: 14.808

6.  Estimation of the phospholipid phosphorus turnover time in man: studies in normal individuals, in patients with the nephrotic syndrome and in other types of hyperlipemia.

Authors:  H W MOSER; K EMERSON
Journal:  J Clin Invest       Date:  1955-08       Impact factor: 14.808

7.  Evaluation of 4β-Hydroxycholesterol as a Clinical Biomarker of CYP3A4 Drug Interactions Using a Bayesian Mechanism-Based Pharmacometric Model.

Authors:  T A Leil; S Kasichayanula; D W Boulton; F LaCreta
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.